Table 2.

Effect of the Addition of Anti-CD3 and Anti-HLA Class I MoAbs on the Cytolytic Activity of LB-Reactive TCC Against Autologous Pretransplant LB

TCC No. Phenotype % of Specific Lysis
Untreated +Anti-CD3 +Anti-HLA Class I
 6* TCR αβ+/CD8+ 35  6  
 8* TCR αβ+/CD8+ 68 9  8  
13* TCR αβ+/CD8/CD4 26  32 28  
15* TCR γδ+/CD8+ 26 30  21  
 2 TCR αβ+/CD8+ 58  26  8  
 7 TCR αβ+/CD8+ 36  6  4  
15 TCR γδ+/CD8+ 15  12  17 
18 TCR γδ+/CD8/CD4 35  30 25 
TCC No. Phenotype % of Specific Lysis
Untreated +Anti-CD3 +Anti-HLA Class I
 6* TCR αβ+/CD8+ 35  6  
 8* TCR αβ+/CD8+ 68 9  8  
13* TCR αβ+/CD8/CD4 26  32 28  
15* TCR γδ+/CD8+ 26 30  21  
 2 TCR αβ+/CD8+ 58  26  8  
 7 TCR αβ+/CD8+ 36  6  4  
15 TCR γδ+/CD8+ 15  12  17 
18 TCR γδ+/CD8/CD4 35  30 25 

Results are expressed as the percentage of specific lysis at an E:T ratio of 5:1.

*

TCC isolated from untreated cultures.

TCC isolated from IT-treated cultures.

Close Modal

or Create an Account

Close Modal
Close Modal